July 2026
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
July 2026
The global transdermal drug delivery systems market size was evaluated at USD 78.20 billion in 2025 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
June 2026
The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
July 2025
The oral transmucosal drugs market size was valued at USD 36.72 billion in 2024 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
July 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
July 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
July 2026
The global RNA interference drug delivery market size is evaluated at USD 118.18 billion in 2025 and is predicted to hit around USD 601.36 billion by 2035, growing at a CAGR of 17.67%.
July 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
July 2026
Genetic editing for ASCVD market booming PCSK9-targeted base editing, lipid nanoparticle delivery and next gen CRISPR therapies reshaping LDL control.
July 2026
The global AI-powered drug formulation market is growing as pharmaceutical companies leverage AI to optimize drug design, delivery, and efficacy.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The global subcutaneous drug delivery devices market size was valued at USD 36.12 billion in 2025 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.29 billion in 2025 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
June 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.07 trillion in 2025 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
June 2026
The global healthcare information systems market size is projected to hit around USD 1,956.49 billion by 2035 from USD 588.39 billion in 2025 with a CAGR of 12.77%.
June 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
April 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 88.85 billion in 2025, growing at a CAGR of 7.28%.
April 2026
The global intranasal drug delivery devices market size surpassed USD 1868.61 million in 2025 and is projected to hit around USD 4949.45 million by 2035, with a noteworthy CAGR of 10%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
April 2026
The global non-clinical information systems market size is projected to hit around USD 40.03 billion by 2035, increasing from USD 18.20 billion in 2025, with a healthy CAGR of 8.20%.
February 2026
The global anti-epileptic drugs for pediatrics market size is estimated to hit around USD 3.25 billion by 2035 increasing from USD 1.50 billion in 2025, with a CAGR of 8.04%.
February 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 20.17 billion in 2025, with a CAGR of 14.63%.
February 2026
The global AI-enabled sorting systems for dark plastics market size was evaluated at USD 526.18 million in 2025 and is predicted to hit around USD 1,573.98 million by 2035, growing at a CAGR of 11.58%.
February 2026
The global performance enhancing drugs market size was evaluated at USD 436.07 million in 2025 and is predicted to hit around USD 892.09 million by 2035, growing at a CAGR of 7.42%.
February 2026
The anesthesia information management systems market size is projected to hit around USD 961.72 billion by 2035 from USD 587.20 billion in 2025 with a CAGR of 5.06%.
January 2026
The injectable drug delivery market size was valued at USD 764.6 billion in 2025 and is projected to hit around USD 1,719.57 billion by 2035 with a CAGR of 8.45%.
December 2025
The global drug formulation market size is calculated at USD 1.96 trillion in 2025 and is projected to hit around USD 3.50 trillion by 2035 with a CAGR of 5.97%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com